Skip to main content

Juan-Sebastian Saldivar, Mark Gold

AltheaDx has appointed Juan-Sebastian Saldivar as chief medical officer and Mark Gold to its board of directors.

Saldivar joins AltheaDx from Sequenom, where he was vice president of clinical services and medical affairs. Previously, he was director of molecular diagnostics and a clinical associate professor in the department of pathology at City of Hope National Medical Center. He also served as director of clinical laboratory services at Perlegen Sciences.

Gold was a distinguished professor in neuroscience and chairman at the University of Florida from 1990 until he retired in June 2014. He has also served as a consultant to banks, private equity firms, global pharmaceutical companies, and venture capital firms on devices, pharmaceuticals and health care delivery. He has served on the board of directors of Viewray and AxoGen.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.